The U.S. Food and Drug Administration this week published its first action plan for how it intends to spur development and oversight of safe, patient-centric artificial intelligence and machine learning-based software as a medical device.

We have the equipment you need to upgrade or install a whole new nurse call system. Let us help you build a customized system that serves the needs of your staff and the patients.

The AI/ML-Based Software as a Medical Device Action Plan is a project of the Digital Health Center of Excellence at FDA’s Center for Devices and Radiological Health, which launched this past September.

The action plan outlines five next steps FDA intends to take as AI/ML-based SaMD continues to evolve:

Continuing to develop its own proposed regulatory framework for draft guidance on a predetermined change control plan for software learning.

Supporting “good machine learning practices” for evaluation of ML algorithms.

Enabling a more transparent patient-centered approach.

Developing new methods to evaluate and improve machine learning algorithms,

Creating new pilots to enable real-world performance monitoring.